The programme of assessment for clinical oncology is described in the curriculum. It comprises an integrated package of formative workplace-based assessments (WPBAs) and summative examination of knowledge and skills, which will sample across the curriculum.
Assessment will take place throughout the training programme to allow trainees to continually gather evidence of learning and to provide the formative feedback essential to improving clinical practice. These assessments will inform judgements made about progress at the annual review of competency progression (ARCP). Decision aids are available to support ARCP panels in making these judgements.
WPBAs should be recorded in the trainee's Kaizen ePortfolio and trainees may also use Kaizen to record other evidence of their progress against the capabilities in practice (CiPs) described in the curriculum.
Guidance on the underpinning scientific knowledge required for the first FRCR examination and the list of anticancer drugs that may be examined can be found below. More information on all of the FRCR examinations can be found on the examinations web page.
- ARCP decision aid
- A guide to using entrustment scales to assess progress
- Guidance for the First FRCR examination: underpinning scientific knowledge
- List of anticancer drugs (applies to examinations held from the spring 2021 sitting)
- Workplace-based assessment guides:
- Guidance for supervisor reports - Coming soon
Please note: ARCP decision aids for 2021 ARCPs (where trainees will be assessed against the 2016 curriculum) have been updated to reflect the impact of COVID-19 on training and derogations to the Gold Guide. The amended decision aids can be found on our 'Trainee progression and coronavirus (COVID-19)' page.